What Happened
Vumedi, an Oakland-based peer-to-peer learning community for physicians, announced expanded AI-powered learning capabilities on November 10, 2026, built on a $104 million Series B growth investment from Oak HC/FT, a venture and growth equity firm specializing in healthcare and technology. The announcement was carried by Business Wire and reported by Dealroom and other outlets.
The company's AI turns more than 100,000 physician-led videos and nearly 5,000 podcast episodes across more than 21 specialties into an on-demand clinical resource. Physicians can ask a clinical question and be connected with the experience of leading specialists faster than by searching through journals or attending conferences.
Since launching less than a year ago, Vumedi's AI tools have been used by more than 150,000 NPI-verified clinicians — physicians whose identities are confirmed through the National Provider Identifier registry — generating more than 1 million interactions. Physicians now spend more than 4.3 million minutes a month learning on the platform, according to the company.
Vumedi has used the capital to invest in talent, research and development, product development, and outreach, expanding the content, features, and formats physicians use to learn from their peers. One point of context: venture databases had previously tracked Vumedi's Series B at around $80 million in May 2025, so the $104 million figure in the November announcement appears to reflect an extension or expansion of the round rather than an entirely new financing.
What the Company Does
Vumedi is a peer-to-peer learning community for physicians, where clinicians learn directly from the experts and peers advancing their field. The company was founded in 2008 by Roman Giverts and is based in Oakland, California, with roughly 277 employees as of late 2026.
The problem Vumedi addresses is the speed of medical knowledge. The timeline for a breakthrough treatment to reach peak adoption in everyday clinical practice has stretched from two to three years to six to seven years, according to the company's announcement. New research, therapies, and treatment approaches appear faster than any individual physician can absorb them, and the traditional channels for keeping up — journals, conferences, continuing-education courses — are slow, expensive, and hard to fit into a clinical schedule.
Vumedi's answer is to organize the knowledge that physicians already share with each other. Specialists record videos and podcasts explaining how they treat specific conditions, which procedures they prefer, and what they have learned from their own patients. The platform collects that material, and its AI makes it searchable and comparable: a doctor facing a difficult case can find what several leading specialists have said about the same problem, and compare their guidance.
The AI layer is the new part. Rather than simply hosting videos, Vumedi's tools index the content and connect a physician's question to the most relevant specialist guidance, drawing on the full library of videos and podcasts.
Why It Matters
Healthcare has a knowledge-distribution problem that is distinct from its other problems. The system spends enormous sums on research and drug development, but the value of that spending depends on clinicians actually using new knowledge — and the evidence suggests they often do so slowly. A platform that shortens the adoption lag by even a year would be worth a great deal, in better outcomes as well as in money.
The scale of early usage is notable. More than 150,000 verified clinicians and more than 1 million AI interactions in under a year suggest that physicians are willing to use an AI tool for learning, even in a profession that is rightly cautious about new technology. The 4.3 million minutes a month of learning time indicates the platform is becoming a habit rather than a one-time experiment.
The investment also reflects a broader trend: AI in healthcare is moving from administrative tasks — scheduling, billing, documentation — into clinical knowledge work. Vumedi does not diagnose patients or recommend treatments for individuals; it helps physicians learn from each other.
Oak HC/FT, the sole investor named in the round, manages more than $10 billion in assets across more than 120 portfolio companies, and its backing signals confidence that physician education is a large and defensible market.
The figures deserve the usual caution: they are self-reported by the company, and usage does not by itself prove clinical impact.
What This Means for Founders and Investors
For founders, Vumedi is a case study in building on an existing professional behavior rather than inventing a new one. Physicians have always learned from each other; Vumedi organized, recorded, and indexed that learning, then added AI to make it searchable. Founders in healthcare and other expert professions should look for the informal knowledge-sharing that already happens in their field, and ask whether it can be structured and scaled.
For investors, the round shows that healthcare AI is finding commercial traction in education and knowledge work, not only in diagnostics and drug discovery. The market is large — every physician in the world needs continuing education — and the business model is straightforward: a platform that physicians use every month can charge for premium access, sponsored content, or enterprise licenses. The risk is that engagement figures do not translate into revenue, and that the platform's value depends on keeping both the specialists who create content and the physicians who consume it.
Angeled.com connects founders with investors.
Dealroom
CFOtech News
Read Next
General Translation Raises $27 Million Series A Led by a16z to Build Agent-First Localization Infrastructure
LangChain Raises $300 Million Led by CapitalG at a $3 Billion Valuation to Build the Agent Stack
Mount Thor Raises $45 Million to Run Cloud Fleets of Macs for AI Agents
OpenAI Reportedly Raises $15 Billion at a $1.25 Trillion Valuation
Q-CTRL Raises $290 Million Series C Led by Salesforce Ventures, Reaching Unicorn Status
SE3 Raises $30 Million Series A Led by Accel



